Substantial portion of cancer patients in early trials access drugs that are later approved, study finds
A paper in the Journal of the National Cancer Institute finds that almost 20% of patients in middle-stage cancer drug trials ...
Ex-Stanford research coordinator convicted of tampering with cancer study database
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
India bans THESE ‘addictive’ drugs to West Africa over misuse concerns: How dangerous are they?
India has banned the export of Tapentadol, Carisoprodol combination drugs to certain West African nations amid report of their misuse in West Africa ...
Crime and Public Safety
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
Cure Today8h
What Patients With Cancer Should Know About DPD Deficiency Prior to Chemo
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...
stocknews9h
3 Pharmaceutical Stocks With Blockbuster Drug Potential
The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...
verywellhealth12h
Why Doctors Say Drinking Raw Milk Is Not Safe
Drinking raw milk is not considered safe because it can contain disease-causing pathogens that cause food poisoning, which ...
Cure Today14h
Zongertinib Receives Priority Review For HER2 Mutant NSCLC
Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...
Bristol Myers Gets Speedy FDA Review of Opdivo/Yervoy Combo in Certain Colorectal Cancer Patients
Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...
NY lawmaker introduces bill to ban Zyn, other flavored nicotine pouches after FDA's support of product
A New York state lawmaker is proposing a ban on the sale of flavored nicotine pouches, even after the FDA authorized the ...
Los Angeles Business Journal22h
ImmunityBio Seeks Drug Approvals
After a momentous 2024, Culver City-based ImmunityBio Inc., the immunotherapy company founded and majority-owned by ...
As the US bans controversial additive red dye 3 - a dietician explains what it is and why it's so harmful
But last month, the US Food & Drug Administration banned the use of the controversial red dye 3 food additive in (most) foods ...